Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections
Open Access
- 12 September 2020
- journal article
- review article
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 20 (6) , 525-533
Abstract
Human factor Xa (FXa) is a serine protease of the common coagulation pathway. FXa is known to activate prothrombin to thrombin, which eventually leads to the formation of cross-linked blood clots. While this process is important in maintaining hemostasis, excessive thrombin generation results in a host of thrombotic conditions. FXa has also been linked to inflammation via protease-activated receptors. Together, coagulopathy and inflammation have been implicated in the pathogenesis of viral infections, including the current coronavirus pandemic. Direct FXa inhibitors have been shown to possess anti-inflammatory and antiviral effects, in addition to their established anticoagulant activity. This review summarizes the pharmacological activities of direct FXa inhibitors, their pharmacokinetics, potential drug–drug interactions and adverse effects, and the details of clinical trials involving direct FXa inhibitors in coronavirus disease 2019 (COVID-19) patients.Keywords
Funding Information
- National Institute of General Medical Sciences (SC3GM131986)
This publication has 82 references indexed in Scilit:
- Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesProceedings of the National Academy of Sciences, 2009
- Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 ActivationThe American Journal of Pathology, 2008
- Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic SurgeryClinical Pharmacokinetics, 2008
- Factor Xa or thrombin: is factor Xa a better target?Journal of Thrombosis and Haemostasis, 2007
- Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivityBiochemical and Biophysical Research Communications, 2007
- Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 siteBlood, 2005
- Review: Infectious Diseases and Coagulation DisordersThe Journal of Infectious Diseases, 1999
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991